News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–12
Matches
12
Sources here
2
Companies here
1
Search results Stored financial headlines

Active search

12 matching headlines

Ticker or company: CURXMain company stories
Clear
Latest

TradingView Earnings

Curanex Pharmaceuticals Inc Q2 2026: Net income $(3.29M), EPS $(0.12) — 10-Q Summary

Curanex Pharmaceuticals Inc (CURX) reported a net loss of $(3.29M) for Q2 2026, with a diluted loss per share of $(0.12), and no revenue as the company remains pre-revenue. This compares to a net loss of $(0.06M) in Q2 2025. The company completed a GMP pilot-scale batch of Phyto-N, targeting an IND submission for ulcerative colitis in Q4 …

Main company 🇺🇸 United States
Read at TradingView
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
Just inNext headlines
TradingView Earnings Main company 🇺🇸 United States

CURX: Net loss rose to $6.4M as R&D spending increased; cash shortfall raises going concern doubts

Curanex Pharmaceuticals Inc (CURX) reported a net loss of $6.4 million for the first half of 2026, primarily due to increased spending on R&D and administrative costs as its lead drug candidate progresses. The company faces significant going concern doubts as its current cash …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc (CURX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Curanex Pharmaceuticals Inc (CURX), including future EPS and revenue growth estimates. It notes the current stock price, market cap, and offers an overview of the company's financial data, technical forecast, and peer comparison. The forecast data was …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc

This article provides a company overview for Curanex Pharmaceuticals Inc (CURX). It shows the stock price, market capitalization, and indicates that revenue breakdown data by business segment and region have not yet been disclosed by the company. The page primarily serves as a placeholder …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc (CURX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Curanex Pharmaceuticals Inc (CURX), detailing its performance based on various technical indicators and moving averages. It summarizes the buy, sell, and neutral signals from indicators like MACD, RSI, and STOCH, as well as the moving averages (MA5 …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc (CURX) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of Curanex Pharmaceuticals Inc (CURX) financial health, focusing on profitability and balance sheet data. It also includes current stock information, such as market cap and recent trading activity. The content appears to be a stub or an introduction to …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc (CURX) Cash Flow

This article provides a detailed cash flow statement for Curanex Pharmaceuticals Inc (CURX), including operating, investing, and financing cash flows, both quarterly and annually. It also offers explanations of key cash flow metrics like operating cash flow, investing cash flow, financing cash flow, and …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc (CURX) Income Statement

This article provides the quarterly income statement for Curanex Pharmaceuticals Inc (CURX), detailing operating expenses, R&D expenses, operating profit, and net income from Q2 2025 to Q1 2026. It also includes frequently asked questions about interpreting income statements and key financial metrics for analyzing …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc (CURX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Curanex Pharmaceuticals Inc (CURX), focusing on its volatility, financial risk, and investment risk. It lists various metrics such as Beta, VaR, Maximum Drawdown, Volatility, Sharpe Ratio, and Liquidity indicators, although most specific data points are "—" which …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc (CURX) Institutional Confidence

This article provides details on the institutional confidence for Curanex Pharmaceuticals Inc (CURX), listing key shareholders and their respective shareholdings. Notable investors include Liu (Jun), Liu (Chang), Jing (Dian Ying), Citadel Advisors LLC, and Two Sigma Investments, LP. The data also indicates recent changes …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

CURX|Curanex Pharmaceuticals Inc|Price:0.188|Chg%:-0.011

This article provides a financial overview of Curanex Pharmaceuticals Inc (CURX), highlighting its latest reported earnings, revenue, and key financial indicators from its income statement, balance sheet, and cash flow statement. It details figures such as EPS, net profit, debt to assets ratio, total …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026
TradingKey Capital return Main company 🇺🇸 United States

Curanex Pharmaceuticals Inc (CURX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Curanex Pharmaceuticals Inc (CURX) dividend and stock split history, indicating that the company has not distributed any dividends over the past five years. It also includes current stock information such as its price, market capitalization, and performance. No …

CURX main company
Sharemaestro market context Price below Trend Line 51 weeks -96.1% · Next-week setup negative 35.1% CURX stored weekly price path from 29 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context